• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD SARS-COV-2 REAGENTS FOR BD MAX¿ SYSTEM; SARS-COV-2 REAGENT KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD SARS-COV-2 REAGENTS FOR BD MAX¿ SYSTEM; SARS-COV-2 REAGENT KIT Back to Search Results
Catalog Number 44500301
Device Problem Microbial Contamination of Device (2303)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/23/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(4).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that mold was discovered in a bd sars-cov-2 reagents for bd max¿ system.(b)(4).The following information was provided by the initial reporter: bd sars cov-2 assay kit (445003-01) lot number 1228397 reported to have mold near the buffer tubes located in the unitised reagent strips.
 
Manufacturer Narrative
H.6.Investigation: the complaint investigation for cosmetic issue on the bd max sars-cov-2 reagents kit (ref #(b)(4)) lot 1228397 was performed by the review of the manufacturing records, retain material inspection, review of customer¿s pictures and by the complaint¿s history review.Review of the manufacturing records of bd max sars-cov-2 reagent indicated that the unitized reagent strip (urs) contained in the kit were manufactured using automated production process and the lot was manufactured according to specifications and met performance requirements.The retain material of bd max sars-cov-2 from lot 1228397 was inspected and all strips were conforming.No anomaly was observed.Pictures were received from the customer for the investigation.Pictures showed black matter around the foil of the buffer wells of 6 consecutive urs.It was confirmed through discussion with the manufacturing engineering team that black matter was indeed burnt trails from the laser beam used to cut the wells' sealing foil.These marks are consistent with observations that were previously observed when the machine has been stopped.The laser is cutting the foil on 6 consecutive urs explaining why only 6 strips are found with those burnt marks.These burnt marks have been assessed and were found to have no impact on product performance nor on the strip's foil seal integrity.There is no indication of a trend for this defect based on the analysis of the complaints received on the bd max sars-cov-2 reagent kit lot 1228397.The root cause was identified as laser burnt mark having no impact on product performance.Bd confirms the complaint for a cosmetic defect based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa) since the issue is isolated and has only a cosmetic impact on the product.Bd quality will continue to monitor for trends.
 
Event Description
It was reported that mold was discovered in a bd sars-cov-2 reagents for bd max¿ system.Eua#: (b)(4).The following information was provided by the initial reporter: bd sars cov-2 assay kit (445003-01) lot number 1228397 reported to have mold near the buffer tubes located in the unitised reagent strips.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD SARS-COV-2 REAGENTS FOR BD MAX¿ SYSTEM
Type of Device
SARS-COV-2 REAGENT KIT
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13285043
MDR Text Key292034643
Report Number1119779-2021-02170
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/18/2022
Device Catalogue Number44500301
Device Lot Number1228397
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/24/2021
Initial Date FDA Received01/18/2022
Supplement Dates Manufacturer Received03/17/2022
Supplement Dates FDA Received03/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-